This report is no longer available. Click here to view our current reports or contact us to discuss a custom report.
If you have previously purchased this report then please use the download links on the right to download the files.
1. | EXECUTIVE SUMMARY |
1.1. | Neuroprosthetics defined |
1.2. | Neuroprosthetic implant examples |
1.3. | Neuroprosthetics- Why now? |
1.4. | Considerations and future directions for neural probes |
1.5. | Considerations, trends, and future directions for cochlear implants |
1.6. | Competitive patent interest in cochlear implants |
1.7. | Considerations, trends, and future directions for retinal implants |
1.8. | Competitive patent interest in retinal implants |
1.9. | Considerations for the future of neuroprosthetic limbs |
1.10. | Incumbent, new, and emerging markets summarized |
1.11. | Overall market drivers and constraints |
1.12. | Overall market forecast for neuroprosthetics by 2028 |
2. | INTRODUCTION TO NEUROPROSTHETICS |
2.1. | Neuroprosthetics defined and the impact of sensory loss |
2.2. | The prevalence and expected rise of macular degeneration |
2.3. | Major players for neural probes and related devices |
2.4. | Outline of a cochlear implant |
2.5. | Cochlear implants |
2.6. | Major players for hearing restoration |
2.7. | Intracortical visual prosthetics |
2.8. | Major players for neuroprosthetic sight restoration |
2.9. | Who could benefit from neuroprosthetic limbs? |
2.10. | Developers of neuroprosthetic limbs |
2.11. | Types of neuroprosthetic limbs |
2.12. | Clinical trials interest in cochlear implants and retinal implants |
2.13. | Incumbent, new, and emerging markets summarized |
2.14. | Market drivers and constraints |
2.15. | Estimated 2017 market size and unit sales forecast for neuroprosthetics |
2.16. | IP interest in neuroprosthetics |
2.17. | NIH BRAIN Initiative® |
3. | MARKET FORECASTS |
3.1. | Cochlear implant revenue by company |
3.2. | Market forecast for cochlear implants- Whole units and revenue by unit |
3.3. | Market forecast for cochlear implants- Revenue by new and upgraded component |
3.4. | The impact of new competitors- a historical perspective |
3.5. | Market forecast for cochlear implants- with potential disruption |
3.6. | The impact of new competitors- potential changes in the average price of cochlear implants |
3.7. | Market forecast for retinal implants- RP only |
3.8. | Regional sales distribution of retinal implants- the impact of reimbursement plans |
3.9. | Market potential for retinal implants- MD |
3.10. | Market forecast for retinal implants- RP + MD |
3.11. | Market forecast considerations for neuroprosthetic limbs |
3.12. | Overall market forecast for neuroprosthetics by 2028 |
4. | COMPETITIVE INTERESTS IN PATENTS AND CLINICAL TRIALS |
4.1. | Competitive patent interest in cochlear implants |
4.2. | Changing cochlear implant price- the role of patents and new competitors |
4.3. | Competitive interest in clinical trials for cochlear implants |
4.4. | The potential impact of new competitors |
4.5. | Cochlear assigned patent timeline |
4.6. | Advanced Bionics assigned patent timeline |
4.7. | MED-EL assigned patent timeline |
4.8. | Oticon assigned patents timeline |
4.9. | Nurotron assigned patent timeline |
4.10. | Competitive patent interest in retinal implants |
4.11. | Second Sight assigned patent timeline |
4.12. | Pixium Vision assigned patent timeline |
4.13. | Competitive interest in clinical trials for retinal implants |
4.14. | Patent interest in neuroprosthetic limbs |
4.15. | Ossur assigned patents timeline |
5. | COMPETITIVE LANDSCAPE FOR NEURAL PROBES |
5.1. | A brief history of neural probes |
5.2. | How neural probes are typically made |
5.3. | Considerations for electrode material selection and insulating materials |
5.4. | Special considerations for neural probes and related devices |
5.5. | Research interest in neural probes |
5.6. | Patent interest in neural probes |
5.7. | NIH BRAIN Initiative® |
5.8. | Intan technology |
5.9. | University of Utah Center for Neural Interfaces |
5.10. | Blackrock Microsystems technologies, partnership, and advances |
5.11. | NeuroNexus technologies, company and collaboration |
5.12. | CorTec technology |
5.13. | Ripple technologies |
5.14. | Cambridge NeuroTech technologies |
5.15. | Wise Srl technology |
5.16. | FHC technology |
5.17. | Neuralynx technology |
5.18. | Ad-Tech technologies |
5.19. | PMT Corporation electrodes |
5.20. | Atlas Neuro probe technology |
5.21. | Microprobes for Life Sciences technologies |
5.22. | Omnectics connectors for neuroscience |
5.23. | University of Texas probe research |
5.24. | SINAPSE©- Singapore Institute for Neurotechnology |
5.25. | Considerations and future directions in neural probes |
6. | COMPETITIVE LANDSCAPE FOR COCHLEAR IMPLANTS |
6.1. | Major technological developments in cochlear implants |
6.2. | Changing cochlear implant price over time |
6.3. | Research interest in cochlear implants |
6.4. | Patent interest in cochlear implants |
6.5. | Competitive patent interest in cochlear implants |
6.6. | Special considerations for cochlear implants |
6.7. | Cochlear Ltd. Technologies |
6.8. | Advanced Bionics technologies |
6.9. | MED-EL technologies |
6.10. | Oticon technologies |
6.11. | Nurotron technologies |
6.12. | Trends and potential future directions in cochlear implants |
6.13. | Specification comparison- Processors & internal implants |
7. | COMPETITIVE LANDSCAPE FOR RETINAL IMPLANTS |
7.1. | A brief history of neuroprosthetics for vision restoration |
7.2. | Special considerations for vision neuroprosthetics |
7.3. | Research interest for retinal implants |
7.4. | Patent interest in retinal implants |
7.5. | Competitive patent interest timeline |
7.6. | Second Sight technologies |
7.7. | Pixium Vision retinal implant technologies |
7.8. | Retina Implant AG Alpha IMS and AMS technology |
7.9. | Nidek Co. Ltd. retinal implant technology |
7.10. | Optibionics retinal implant technology |
7.11. | Nano Retina technology |
7.12. | Bionic Vision Technologies development |
7.13. | Nanovision Biosciences technology |
7.14. | Bionic Eye Technologies, Inc. technology |
7.15. | Monash Vision Group technology |
7.16. | Illinois Institute of Technology's Intracortical Visual Prosthesis (ICVP) |
7.17. | Natcore Technology's retinal implant technology |
7.18. | LambdaVision protein-based retinal implant |
7.19. | VisionCare's implantable miniature telescope |
7.20. | Retinal implant specification comparison |
7.21. | Trends and potential future directions for neuroprosthetic vision technology |
8. | COMPETITIVE LANDSCAPE FOR NEUROPROSTHETIC LIMBS |
8.1. | A brief history of prosthetic limbs |
8.2. | Research interest in neuroprosthetic limbs |
8.3. | Patent interest in neuroprosthetic limbs |
8.4. | Special considerations for neuroprosthetic limbs |
8.5. | SensArs technology |
8.6. | Ossur technology |
8.7. | DARPA programs |
8.8. | Mobius Bionics technology |
8.9. | Case Western Reserve University and the Functional Neural Interface Lab |
8.10. | Biomechatronics at MIT Media Lab |
8.11. | The University of Utah and Blackrock Microsystems |
8.12. | Ripple technology |
8.13. | Paradromics technology |
8.14. | CorTec technology |
8.15. | Synchron technology |
8.16. | UMC Utrecht and their Utrecht Neuroprosthesis technology |
8.17. | BrainGate technology |
8.18. | Andersen Lab at Caltech |
8.19. | Schwartz Motorlab at the University of Pittsburgh |
8.20. | The University of Pittsburgh with DARPA |
8.21. | Medtronic's spinal cord stimulation technology |
8.22. | A consideration for the future of neuroprosthetic limbs |
9. | COMPANY PROFILES |
9.1. | Bionic Eye Technologies |
9.2. | CorTec GmbH |
9.3. | Nurotron Biotechnology |
9.4. | Pixium Vision |
9.5. | Retina Implant AG |
9.6. | Second Sight Medical Products, Inc. |
Slides | 280 |
---|---|
Forecasts to | 2028 |